Published in Hautarzt on May 01, 1972
Treatment of gonorrhoea with penicillin, cephaloridine, and doxycycline. Br J Vener Dis (1973) 1.07
The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol (1984) 2.70
A shared antigenic determinant between natural killer cells and nervous tissue. Nature (1984) 2.24
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy (2003) 2.08
HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity (1995) 2.07
Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry (2001) 1.93
The gene coding for the major birch pollen allergen Betv1, is highly homologous to a pea disease resistance response gene. EMBO J (1989) 1.93
Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry (1999) 1.90
Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy (1997) 1.80
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70
Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy (2002) 1.63
Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science (1991) 1.62
The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol (1995) 1.59
A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil. J Infect Dis (1988) 1.56
Prevention of latex allergy by selection of low-allergen gloves. Clin Exp Allergy (2000) 1.55
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1. Clin Exp Allergy (2004) 1.55
Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med (1996) 1.51
The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy (1999) 1.51
Formaldehyde-induced anaphylaxis after dental treatment? Contact Dermatitis (1991) 1.44
Marker of peripheral blood granulocytes and monocytes of man recognized by two monoclonal antibodies VEP8 and VEP9 involves the trisaccharide 3-fucosyl-N-acetyllactosamine. Eur J Immunol (1983) 1.41
Venoconstrictive thigh cuffs impede fluid shifts during simulated microgravity. Aviat Space Environ Med (1998) 1.40
Profilins constitute a novel family of functional plant pan-allergens. J Exp Med (1992) 1.35
Mefloquine concentration profiles during prophylactic dose regimens. Wien Klin Wochenschr (2000) 1.31
Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol (1996) 1.30
Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J (1998) 1.28
Cytoplasmic antibodies in patients with systemic lupus erythematosus. Ann N Y Acad Sci (1965) 1.27
Cloning and sequencing of Mal d 1, the major allergen from apple (Malus domestica), and its immunological relationship to Bet v 1, the major birch pollen allergen. Biochem Biophys Res Commun (1995) 1.25
A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes. J Immunol (1982) 1.24
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy. J Clin Invest (1997) 1.22
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J (2001) 1.21
IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa. Allergy (1989) 1.21
Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine (2001) 1.18
Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol (1999) 1.17
Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. Trans R Soc Trop Med Hyg (1995) 1.16
Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon. J Exp Med (1989) 1.16
Is there a role for continuation phase cognitive therapy for depressed outpatients? J Consult Clin Psychol (1998) 1.16
Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens. Clin Exp Allergy (2004) 1.15
Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol (1995) 1.14
Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation. Acta Neuropathol (1990) 1.14
Anaphylaxis due to hydroxyethyl-starch-reactive antibodies. Lancet (1995) 1.11
Immunotherapy of allergic disease. Adv Immunol (2004) 1.10
Isoforms of Bet v 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry, and cDNA cloning. J Biol Chem (1995) 1.10
Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol (1995) 1.09
Common epitopes of birch pollen and apples--studies by western and northern blot. J Allergy Clin Immunol (1991) 1.09
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. FASEB J (2001) 1.08
In vivo demyelinating activity of sera from animals with chronic experimental allergic encephalomyelitis. Antibody nature of the demyelinating factor and the role of complement. J Neurol Sci (1983) 1.07
Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica. J Exp Med (1997) 1.07
Boosting properties of recombinant DNA hepatitis B vaccine. Lancet (1986) 1.07
In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance. Am J Trop Med Hyg (2001) 1.07
IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. J Allergy Clin Immunol (1998) 1.07
cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen. J Immunol (1993) 1.07
Molecular and immunological characterization of arginine kinase from the Indianmeal moth, Plodia interpunctella, a novel cross-reactive invertebrate pan-allergen. J Immunol (2001) 1.06
Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol (1995) 1.06
Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. Antimicrob Agents Chemother (2001) 1.05
Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1. J Immunol (1996) 1.04
Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol (1997) 1.03
Compliance of Austrian tourists with prophylactic measures. Eur J Epidemiol (1992) 1.01
Microarrayed recombinant allergens for diagnosis of allergy. Clin Exp Allergy (2003) 1.01
Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J Allergy Clin Immunol (2000) 1.01
Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves. Br J Dermatol (1997) 1.00
High-level expression and purification of the major birch pollen allergen, Bet v 1. Protein Expr Purif (1997) 1.00
Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol (1993) 1.00
Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth (1999) 1.00
[Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study]. Fortschr Med (1993) 0.99
Elimination of ampicillin and gentamicin by hemofiltration. Klin Wochenschr (1979) 0.99
T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. J Immunol (2000) 0.98
Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination. Clin Exp Allergy (2004) 0.98
Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1. Clin Exp Immunol (1997) 0.98
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood (2001) 0.98
Specific and total serum IgE measurements in the diagnosis of penicillin allergy. A long term follow-up study. Clin Allergy (1977) 0.97
Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice. Int Arch Allergy Immunol (2001) 0.97
Molecular cloning and characterization of profilin from tobacco (Nicotiana tabacum): increased profilin expression during pollen maturation. Plant Mol Biol (1995) 0.96
Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT). Br J Haematol (1987) 0.96
Molecular characterization of dog albumin as a cross-reactive allergen. J Allergy Clin Immunol (1994) 0.96
[Hydroxyethyl starch accumulation in the skin with special reference to hydroxyethyl starch-associated pruritus]. Dtsch Med Wochenschr (2000) 0.96
Molecular characterization of Api g 1, the major allergen of celery (Apium graveolens), and its immunological and structural relationships to a group of 17-kDa tree pollen allergens. Eur J Biochem (1995) 0.96
Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding properties. Eur J Biochem (1993) 0.95
Identification of common allergenic structures in hazel pollen and hazelnuts: a possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen. J Allergy Clin Immunol (1992) 0.95
Molecular characterization of Bip 1, a monoclonal antibody that modulates IgE binding to birch pollen allergen, Bet v 1. J Immunol (1996) 0.95
Clinical patterns and results of radioallergosorbent test (RAST) and skin tests in penicillin allergy. Br J Dermatol (1976) 0.95
B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy. FASEB J (1999) 0.95
Expression of leucocyte adhesion molecules at the human blood-brain barrier (BBB). J Neurosci Res (1992) 0.95
Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur J Immunol (1999) 0.95
Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. Acta Trop (2001) 0.95
Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. J Biol Chem (1996) 0.95
Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy (2003) 0.95
Identification of common allergenic structures in mugwort and ragweed pollen. J Allergy Clin Immunol (1998) 0.95
Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia (1972) 0.95
Defective intralesional interferon-gamma activity in patients with lepromatous leprosy. Clin Exp Immunol (1988) 0.94
Type 1 allergic reactions to plant-derived food: a consequence of primary sensitization to pollen allergens. J Allergy Clin Immunol (1996) 0.94
Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects. Postgrad Med J (1987) 0.94
Preferences as expectation-driven inferences: effects of affective expectations on affective experience. J Pers Soc Psychol (1989) 0.94
Toxocara infestations in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti-IgE immune complexes. Parasite Immunol (1998) 0.94
IgE cross-reactivities against albumins in patients allergic to animals. J Allergy Clin Immunol (1995) 0.93
Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p2, Phl p 5). J Allergy Clin Immunol (1996) 0.93
Surface characteristics of the human K (killer) lymphocyte. Int Arch Allergy Appl Immunol (1977) 0.93
Isolation of an immunodominant IgE hapten from an epitope expression cDNA library. Dissection of the allergic effector reaction. J Biol Chem (1994) 0.93